A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Eastern Cooperative Oncology Group
OHSU Knight Cancer Institute
Rutgers, The State University of New Jersey
Barbara Ann Karmanos Cancer Institute
Northwestern University
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center